A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma

Exclusion Criteria

• •1. Nodular lymphocyte predominant Hodgkin lymphoma.
• •2. Cerebral/meningeal disease, including signs and symptoms of progressive multifocalleukoencephalopathy (PML).
• •3. Sensory or motor peripheral neuropathy.
• •4. Prior immunosuppressive chemotherapy, therapeutic radiation, or any immunotherapy within 12 weeks of first study drug dose.
• •5. Known human immunodeficiency virus (HIV) positive.
• •6. Known hepatitis B surface antigen-positive, or known or suspected active hepatitis C infection.